Which companies overlap with Biomedical Advanced Research and Development Authority's portfolio?

No competitive overlap detected.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/biomedical-advanced-research-and-development-authority.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Biomedical Advanced Research and Development Authority — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Biomedical Advanced Research and Development Authority pipeline: 3 marketed, 0 filed, 1 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

3 marketed 0 filed 1 Phase 3 1 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
VN	VN	marketed	live, attenuated vaccine		Infectious Disease
BioThrax	BioThrax	marketed
Atropine Sulfate Ophthalmic Solution	Atropine Sulfate Ophthalmic Solution	marketed
AV7909	AV7909	phase 3	Anthrax vaccine	Anthrax protective antigen (PA)	Immunology / Infectious Disease

Therapeutic area mix

Immunology / Infectious Disease · 1
Infectious Disease · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

No competitive overlap data.

Subscribe to ongoing alerts

Every new pipeline event for Biomedical Advanced Research and Development Authority:

Cite this brief

Drug Landscape (2026). Biomedical Advanced Research and Development Authority — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/biomedical-advanced-research-and-development-authority. Accessed 2026-05-17.